DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 216 filers reported holding DENALI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $739 | +163.9% | 35,800 | +277.9% | 0.01% | +300.0% |
Q2 2023 | $280 | -67.4% | 9,474 | -74.6% | 0.00% | -80.0% |
Q1 2023 | $859 | +581.7% | 37,291 | +720.3% | 0.01% | +400.0% |
Q4 2022 | $126 | -100.0% | 4,546 | -64.6% | 0.00% | -60.0% |
Q3 2022 | $394,000 | -65.9% | 12,851 | -67.3% | 0.01% | -58.3% |
Q2 2022 | $1,157,000 | +300.3% | 39,316 | +337.8% | 0.01% | +500.0% |
Q1 2022 | $289,000 | -80.2% | 8,980 | -72.6% | 0.00% | -75.0% |
Q4 2021 | $1,463,000 | -6.2% | 32,802 | +6.2% | 0.01% | +14.3% |
Q3 2021 | $1,559,000 | +15.1% | 30,895 | +78.9% | 0.01% | +16.7% |
Q2 2021 | $1,355,000 | -12.7% | 17,270 | -36.5% | 0.01% | -25.0% |
Q1 2021 | $1,552,000 | -27.7% | 27,178 | +6.1% | 0.01% | -27.3% |
Q4 2020 | $2,146,000 | -28.0% | 25,619 | -69.2% | 0.01% | -42.1% |
Q3 2020 | $2,979,000 | +504.3% | 83,147 | +308.0% | 0.02% | +375.0% |
Q2 2020 | $493,000 | +26.4% | 20,381 | -8.5% | 0.00% | 0.0% |
Q1 2020 | $390,000 | +47.2% | 22,286 | +46.6% | 0.00% | +100.0% |
Q4 2019 | $265,000 | -50.7% | 15,200 | -56.7% | 0.00% | -50.0% |
Q3 2019 | $538,000 | +174.5% | 35,110 | +271.8% | 0.00% | +300.0% |
Q2 2019 | $196,000 | -5.8% | 9,442 | +5.2% | 0.00% | -50.0% |
Q1 2019 | $208,000 | – | 8,975 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |